update | Bundled knowledge in Health
Tina Zembacher | Director Sales LSI (Life Sciences International):
| "Generally speaking, update’s strength is that we offer a standardized pharmaceutical solution which is quick to implement and which clients can administer, adapt and expand, simply and inexpensively. A fast ROI and a low TCO are decisive criteria for our development. And given the acquisition of Regware and the broadened customer base, and as a result of the synergy effects at the ICCH, we will be able in future to respond even more quickly to new market demands. Our strategic objective of CRM market leadership for the sector is absolutely realistic." |
With our business solution update.healthcare, we offer pharmaceutical and medical technology firms as well as clinic operators a product range which caters for the demands of these sectors to the highest degree even in the standard version. Apart from the operative and collaborative CRM solutions, the range also contains an analysis tool with which even external data e.g. IMS for pharmaceutical companies can be analysed and interpreted.











